{"id":54619,"date":"2025-08-19T10:45:31","date_gmt":"2025-08-19T08:45:31","guid":{"rendered":"https:\/\/gsk.de\/?p=54619"},"modified":"2025-08-19T10:45:32","modified_gmt":"2025-08-19T08:45:32","slug":"deal-beams-technology-korndoerfer-en","status":"publish","type":"post","link":"https:\/\/gsk.de\/en\/deal-beams-technology-korndoerfer-en\/","title":{"rendered":"GSK\u00a0Stockmann advises shareholders on Beams Exit"},"content":{"rendered":"\n<p><strong>GSK&nbsp;Stockmann has advised the shareholders of Beams Technology GmbH, Berlin, Germany, on their divestment to Insight Partners and Liberty Hall Capital Partners backed Comply365 Group. Comply365 is a leading provider of Operational Content Management, Safety Management and Training Management in the highly regulated industries of aviation, defense, rail and space.<\/strong><\/p>\n\n\n\n<p>Beams has pioneered a Safety AI solution for the aviation industry to automate safety data processing and enable proactive, predictive risk management. The acquisition accelerates Comply365\u2019s investment in the development of an industry-first, AI platform across operations, safety, and training management. More details can be found in the <a href=\"https:\/\/beams.tech\/about\/news\/comply365-announces-acquisition-of-beams\">official deal notification<\/a>.<\/p>\n\n\n\n<p>A GSK&nbsp;Stockmann team led by Berlin-based partner Robert Kornd\u00f6rfer advised the Beams shareholders on all legal and tax aspects of the divestment.<\/p>\n\n\n\n<p>GSK&nbsp;Stockmann\u2019s M&amp;A\/private equity team regularly advises strategic investors and financial sponsors on domestic and cross-border buy-out and exit transactions. It consists of more than 50 lawyers working together seamlessly across our seven offices and all practice areas of GSK Stockmann.<\/p>\n\n\n\n<p><strong>Advisers of the shareholders of Beams Technology GmbH at GSK\u00a0Stockmann:<\/strong><\/p>\n\n\n\n<p>Robert Kornd\u00f6rfer (lead, Partner, Corporate), Daniel Fehling (Partner, Corporate), Stephan Wachsmuth (Local Partner, Tax), Dominik Berka (Local Partner, Tax), Nicole Deparade (Local Partner, Employment), Dr Martin Hossenfelder (Counsel, IP\/IT); Clara L\u00f3pez Hernando (Senior Associate, Corporate), Raphaela Guderian (Associate, Employment), Katrin Zukovskaja (Associate, Employment)<\/p>\n\n\n\n<p><strong>Other advisers:<\/strong><\/p>\n\n\n\n<p>Willkie Farr &amp; Gallagher for the Comply365 Group<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GSK\u00a0Stockmann has advised the shareholders of Beams Technology GmbH, Berlin on their divestment to Insight Partners and Liberty Hall Capital Partners backed Comply365 Group. <\/p>\n","protected":false},"author":47,"featured_media":51057,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[402],"tags":[],"ausgabe":[675],"verknuepfung":[763,752,766,775,783],"class_list":["post-54619","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-deal-news","ausgabe-gsk","verknuepfung-corporate","verknuepfung-employment-compensation-and-benefits","verknuepfung-ip-it-en","verknuepfung-ma-en","verknuepfung-tax"],"acf":{"ansprechpartner":[{"anwalt":46949},{"anwalt":47939},{"anwalt":19116},{"anwalt":761},{"anwalt":803},{"anwalt":873},{"anwalt":34359},{"anwalt":35742},{"anwalt":51390}],"standard_text":true,"custom_text":false,"postdownloads":false,"pressekontakt":{"email":"","phone":""}},"info":{"date":"19.08.2025","author":"Christina Holl","categories_names":["Deal News"],"category":"Deal News"},"wpml_main_post_id":54617,"featured_img_src":"https:\/\/gsk.de\/wp-content\/uploads\/2024\/06\/Korndoerfer_Robert_1540x900px-1024x598.jpg","_links":{"self":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts\/54619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/users\/47"}],"replies":[{"embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/comments?post=54619"}],"version-history":[{"count":1,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts\/54619\/revisions"}],"predecessor-version":[{"id":54620,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts\/54619\/revisions\/54620"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/media\/51057"}],"wp:attachment":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/media?parent=54619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/categories?post=54619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/tags?post=54619"},{"taxonomy":"ausgabe","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/ausgabe?post=54619"},{"taxonomy":"verknuepfung","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/verknuepfung?post=54619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}